Skip to content

A study to evaluate the safety and effectiveness of the NICAST Polyurethane vascular access graft

A prospective open label randomized clinical study to evaluate the safety and effectiveness of the NICAST polyurethane vascular access graft

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
SLCTR
Registry ID
SLCTR/2008/009
Enrollment
30
Registered
2008-05-16
Start date
2007-07-07
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Using NICAST polyurethane graft for vascular access for haemodialysis in chronic renal failure patients.

Interventions

Use NICAST graft as a arteriovenous conduit for vascular access in haemodialysis in chronic renal failure patients

Sponsors

Nicast Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Candidates for implantattion of a prosthetic vascular access graft for haemodialysis access.these are patients who are not eligible for creation of native fistulae according to the standard of care in the medical center 2. Male or female subjects 18 year or older of any race 3. Subjects willing to participate as evidenced by signing the written informed consent

Exclusion criteria

Exclusion criteria: Subjects with any medical condition that would expose the subject to increased risk by the investigational device or procedure according to the investigator's decision Subjects with elevated WBC counts Subjects with bilirubin level >3mg/dl Concurrent existence of another vascular access graft in the same limb Subjects with known hypersensitivity or allergy to polyurethane products or any other contraindication to implantation of a polyurethane graft Female subjects who are pregnant or lactating Subjects participating in any other clinical study at the same time

Design outcomes

Primary

MeasureTime frame
•Primary patency •Incidence of thrombosis •18 month functional patency rates •Overall incidence of intraoperative and postoperative complications []

Secondary

MeasureTime frame
-Time to first puncture of the graft -Frequency of temporary catheter use prior to first puncture -Difficulty of graft puncture -Haemostasis time []

Countries

Sri Lanka

Contacts

Public ContactMandika Wijeyaratne

Head, Department of Surgery,

mandika59@hotmail.com

Outcome results

None listed

Source: SLCTR (via WHO ICTRP) · Data processed: Aug 9, 2026